How Sleep and Wakefulness Regulated At Cellular Level
Researchers at Boston University School of Medicine (BUSM) have identified an intracellular signaling enzyme that regulates the wake-sleep cycle, which could help lead to the development of more effective sleep aid medications. Subimal Datta, PhD, director and principal investigator at the Laboratory of Sleep and Cognitive Neuroscience at BUSM, led the study, which points to a specific enzyme inside neurons in the brain that trigger an important shift in consciousness from sleep to wakefulness and wakefulness to sleep.
The results are published in the November 23 issue of the Journal of Neuroscience.
“Sleep, one of the most mysterious regular shifts in consciousness, is regulated by a delicate balance between biological processes, the environment, and behavior, but the mechanisms involved in the regulation are not well understood,” said Datta, who also is a professor of psychiatry and neurology at BUSM. “The ultimate goal of my research is to deepen the understanding of how sleep is regulated at the cellular level, which could lead to finding the causes and cures for a variety of sleep disorders.”
Previous research has shown that pedunculopontine tegmentum (PPT) nuclei in the brain play a key role in the regulation of REM sleep and wakefulness. Datta and his colleagues identified that an enzyme, calcium/calmodulin kinase (CaMKII), plays a crucial role in the intracellular pathway for sleep regulation and is necessary for the promotion of wakefulness and suppression of sleep. During the study when the activation of the CaMKII enzyme was blocked using an inhibitor named KN-93, natural REM and non-REM sleep occurred, whereas when the enzyme was activated, wakefulness occurred. Additionally, very minimal doses of therapeutic agents were required to activate or block the system.
According to Datta, this finding opens up the possibility for a new generation of target-specific drugs that could be effective at lower doses. “Current treatments for sleep disorders do not achieve the ideal behavioral outcome, and are usually accompanied by many undesirable side effects,” Datta explained. “A more specific, fine-tuned approach to treating these disorders by promoting alertness and treating insomnia would greatly benefit the public health of our country.”[ Source:SleepReview]
Like this post? Subscribe to my RSS feed and get loads more!